Tech Company Financing Transactions
Eximia Research Network Funding Round
Eximia Research Network, based in Dover, secured investment capital from Veronis Suhler Stevenson.
Transaction Overview
Company Name
Announced On
10/4/2023
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Eximia, in a close partnership with clinical trial sponsors, accelerates the drug approval process by enhancing its key delivery components, focusing on patient centric recruitment and engagement, rapid study start up and data integrity.
Company Information
Company Status
Private & Independent
Industry
AdTech
Mailing Address
108 Lakeland Avenue
Dover, DE 19901
USA
Dover, DE 19901
USA
Phone
Undisclosed
Website
Email Address
Overview
Provider of multi-therapeutic clinical trial research services intended to serve pharmaceutical companies, biotech companies, and contract research organizations (CROs). The company offers a centralized approach with a single point of contact for site identification, study implementation, trial management, recruitment and retention, advertising, contracting, continuous training and quality control.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ella Grach
Browse more venture capital transactions:
Prev: 10/4/2023: Swag Golf venture capital transaction
Next: 10/4/2023: Blackbird Labs venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs